February 16, 2025 10:00 View More GLP-1 Agonists: The Medical Revolution Beyond Weight Loss In this podcast episode, McCall McPherson, a medical professional from the Modern Thyroid Clinic, explores the benefits of GLP-1 agonists, originally developed for diabetes
Science Translational Medicine, 3(108), 108ra112
It is from the same HGF/c-Met lineage as dihexa, loosely described as a dihexa-derived prodrug, and it represented the one serious attempt to take this mechanism into human beings
The process exhibits a dual role in tumorigenesis by promoting as well as suppressing tumors (167)
This hypothesis was supported in a recent study with a 20-year follow-up, which found chronic low dose exposure to POPs predicted excess adiposity, dyslipidemia, and insulin resistance among participants without diabetes, in a U-shaped fashion (characteristic of endocrine disruption)
When glutathione is low, cells can get damaged more easily